BR112012015682A2 - composição transportadora. - Google Patents
composição transportadora.Info
- Publication number
- BR112012015682A2 BR112012015682A2 BR112012015682A BR112012015682A BR112012015682A2 BR 112012015682 A2 BR112012015682 A2 BR 112012015682A2 BR 112012015682 A BR112012015682 A BR 112012015682A BR 112012015682 A BR112012015682 A BR 112012015682A BR 112012015682 A2 BR112012015682 A2 BR 112012015682A2
- Authority
- BR
- Brazil
- Prior art keywords
- carrier composition
- present
- formulated
- formulation
- relatively high
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
composição transportadora. uma composição transportadora da presente invenção compreende um composto de fosfato de um agente de transferência de elétrons e uma concentração relativamente elevada de um solvente polar prótico. um composto biologicamente ativo pode ser formulado com uma composição transportadora da presente invenção para proporcionar uma formulação.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28950709P | 2009-12-23 | 2009-12-23 | |
PCT/AU2010/001719 WO2011075775A1 (en) | 2009-12-23 | 2010-12-22 | Carrier composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012015682A2 true BR112012015682A2 (pt) | 2019-09-24 |
Family
ID=44194821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012015682A BR112012015682A2 (pt) | 2009-12-23 | 2010-12-22 | composição transportadora. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20120202780A1 (pt) |
EP (1) | EP2516011B1 (pt) |
JP (1) | JP5841062B2 (pt) |
KR (1) | KR20120107963A (pt) |
CN (1) | CN102686279B (pt) |
AU (1) | AU2010336018B2 (pt) |
BR (1) | BR112012015682A2 (pt) |
CA (1) | CA2785242A1 (pt) |
ES (1) | ES2643643T3 (pt) |
IL (1) | IL220490A0 (pt) |
MX (1) | MX2012007412A (pt) |
NZ (1) | NZ600773A (pt) |
RU (1) | RU2577233C2 (pt) |
SG (1) | SG181808A1 (pt) |
WO (1) | WO2011075775A1 (pt) |
ZA (1) | ZA201204369B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
MX2012011355A (es) | 2010-03-30 | 2012-11-30 | Phosphagenics Ltd | Parche de suministro transdermico. |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
JP6449554B2 (ja) * | 2014-03-30 | 2019-01-09 | 小林製薬株式会社 | 外用医薬組成物 |
RU2742650C2 (ru) * | 2015-12-09 | 2021-02-09 | Фосфейдженикс Лимитед | Фармацевтический состав |
AU2016367708B2 (en) * | 2015-12-09 | 2022-07-14 | Phosphagenics Limited | Pharmaceutical formulation |
WO2017143360A1 (en) * | 2016-02-18 | 2017-08-24 | Drabinsky Michael Earl | Treatment for microbial borne illness |
KR102647670B1 (ko) | 2016-12-21 | 2024-03-15 | 아베초 바이오테크놀로지 리미티드 | 방법 |
KR20240068806A (ko) * | 2022-10-28 | 2024-05-20 | 주식회사 오가시스 | κ-오피오이드 수용체의 아고니스트를 포함하는 피부 미백용 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2657526B1 (fr) * | 1990-01-31 | 1994-10-28 | Lvmh Rech | Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues. |
AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
WO2002040033A1 (en) * | 2000-11-14 | 2002-05-23 | Vital Health Sciences Pty Ltd | Formulation containing phosphate derivatives of electron transfer agents |
MXPA04000654A (es) * | 2001-07-27 | 2004-03-19 | Vital Health Sciences Pty Ltd | Terapia dermica usando derivados de fosfato de agente de transferencia de electrones. |
CA2466536C (en) * | 2001-12-13 | 2012-02-07 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
FR2846651B1 (fr) * | 2002-10-30 | 2006-06-16 | Rhodia Polyamide Intermediates | Procede de fabrication d'acides carboxyliques |
ATE534384T1 (de) * | 2003-01-17 | 2011-12-15 | Vital Health Sciences Pty Ltd | Verbindungen mit proliferationshemmenden eigenschaften |
EP1893159B1 (en) * | 2005-06-17 | 2015-09-30 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents |
RU2373957C2 (ru) * | 2006-10-13 | 2009-11-27 | Александр Метталинович Тишин | Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его |
-
2010
- 2010-12-22 CA CA2785242A patent/CA2785242A1/en not_active Abandoned
- 2010-12-22 SG SG2012045183A patent/SG181808A1/en unknown
- 2010-12-22 US US13/501,494 patent/US20120202780A1/en not_active Abandoned
- 2010-12-22 KR KR1020127015752A patent/KR20120107963A/ko not_active Application Discontinuation
- 2010-12-22 BR BR112012015682A patent/BR112012015682A2/pt not_active IP Right Cessation
- 2010-12-22 ES ES10838415.7T patent/ES2643643T3/es active Active
- 2010-12-22 RU RU2012126143/15A patent/RU2577233C2/ru not_active IP Right Cessation
- 2010-12-22 WO PCT/AU2010/001719 patent/WO2011075775A1/en active Application Filing
- 2010-12-22 AU AU2010336018A patent/AU2010336018B2/en active Active
- 2010-12-22 MX MX2012007412A patent/MX2012007412A/es not_active Application Discontinuation
- 2010-12-22 JP JP2012545015A patent/JP5841062B2/ja active Active
- 2010-12-22 CN CN201080058887.XA patent/CN102686279B/zh active Active
- 2010-12-22 NZ NZ600773A patent/NZ600773A/en unknown
- 2010-12-22 EP EP10838415.7A patent/EP2516011B1/en active Active
-
2012
- 2012-06-14 ZA ZA2012/04369A patent/ZA201204369B/en unknown
- 2012-06-18 IL IL220490A patent/IL220490A0/en unknown
-
2016
- 2016-07-25 US US15/218,719 patent/US20160331838A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2516011A1 (en) | 2012-10-31 |
NZ600773A (en) | 2014-04-30 |
WO2011075775A1 (en) | 2011-06-30 |
IL220490A0 (en) | 2012-08-30 |
CA2785242A1 (en) | 2011-06-30 |
US20120202780A1 (en) | 2012-08-09 |
US20160331838A1 (en) | 2016-11-17 |
JP5841062B2 (ja) | 2016-01-06 |
JP2013515012A (ja) | 2013-05-02 |
CN102686279A (zh) | 2012-09-19 |
MX2012007412A (es) | 2012-07-17 |
EP2516011B1 (en) | 2017-07-12 |
AU2010336018B2 (en) | 2015-10-01 |
KR20120107963A (ko) | 2012-10-04 |
EP2516011A4 (en) | 2013-07-03 |
SG181808A1 (en) | 2012-07-30 |
AU2010336018A1 (en) | 2012-07-05 |
RU2012126143A (ru) | 2014-01-27 |
ES2643643T3 (es) | 2017-11-23 |
ZA201204369B (en) | 2013-02-27 |
RU2577233C2 (ru) | 2016-03-10 |
CN102686279B (zh) | 2015-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012015682A2 (pt) | composição transportadora. | |
BR112012019508A2 (pt) | composição de veículo | |
BR112012022774A2 (pt) | Composição sólida compreendendo primeira e segunda dispersões sólidas amorfas | |
BR112013006341A2 (pt) | formulações agrícolas líquidas com estabilidade aperfeiçoada | |
CL2015001984A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
CO6260093A2 (es) | Derivados de sulfonil amida para el tratamiento del crecimiento celular anormal | |
AR068195A1 (es) | Composiciones y metodos para el tratamiento de semillas | |
PE20160854A1 (es) | Inhibidores de nitrificacion disenados para fertilizantes a base de estiercol y urea | |
CL2009000393A1 (es) | Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular. | |
BR112012018761A2 (pt) | estruturas para prevenir fixação de microorganismos | |
BR112012026801A2 (pt) | conjugados de pirrolobenzodiazepina direcionados. | |
BR112014004460A2 (pt) | material polimérico para um recipiente isolado | |
RS54815B1 (sr) | Supstanca koja sadrži antibiotik i disperzant | |
BR112014000178A2 (pt) | composições tópicas | |
UY33832A (es) | Inhibidores de la faah. | |
BR112015013437A2 (pt) | composição de revestimento; e lata ou embalagem utilizável para acondicionar alimentos | |
CA2885848C (en) | Non-irritating lubricant compositions with active sensorial agents | |
BR112019024760A2 (pt) | uso de dodecano, composição inoculante líquida, semente de planta revestida, kit, e, método. | |
EA201390612A1 (ru) | Биоразлагаемая композиция для доставки лекарственного средства | |
SV2013004451A (es) | Compuestos y su uso | |
BR112012007798A2 (pt) | microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas | |
AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
BR112012028037A2 (pt) | formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit | |
MX344324B (es) | Endoprotesis que contiene un recubrimiento de substancia activa. | |
AR082771A1 (es) | Composicion de formulacion agroquimica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |